Ask five providers what mass tort leads cost and you will get five sales calls instead of five numbers. That hides a truth worth knowing before you shop: mass tort is the one corner of legal marketing where a single published price would be a warning sign, not a convenience. When firms buy mass tort leads, the price is built from the litigation itself, and any number quoted before a provider asks about your tort and your criteria is a number invented to start a conversation.
This post explains the three ways firms actually buy mass tort cases, what drives the price in each model, and the questions that separate a real quote from a placeholder.
The three ways firms buy
Per lead. You pay for each qualified claimant delivered to your firm. Your team handles intake from there: the calls, the follow up, the records chase, and the signing. This is the lowest unit price of the three models because the labor and the conversion risk stay with you. A cheap lead your team never reaches is not cheap.
Per signed case. On campaigns where the provider offers intake and signing, you pay for a claimant who has been qualified against your criteria and signed on your firm’s own retainer agreement. You pay more per unit and skip the intake stage entirely. Whether that trade makes sense depends on your intake capacity, the same calculation firms run when they compare leads and retainers in any practice area.
Per campaign. You fund a campaign scoped to one litigation, with an agreed geography, criteria, and duration, and the qualified claimants it produces are yours. This is how most serious mass tort buying actually works, because the economics of finding claimants only make sense at the level of a whole docket, not one name at a time.
What actually drives the number
Whichever model you buy under, the same forces set the price. A provider who cannot explain each one for your specific tort is guessing.
The tort itself. A mature litigation involving a well known product and a large affected population produces claimants more easily than a new or narrow docket where eligible people are rare. Scarcity is the biggest single cost driver in this market, and it changes as litigations develop.
How strict your criteria are. Requirements on diagnosis, treatment, timeframe of use or exposure, and documentation decide how many real claimants exist. Every filter you add removes people from the pool. Fewer qualifying claimants means a higher cost per lead and lower available volume, and an honest provider shows you that tradeoff before you order instead of after.
Geography. National campaigns and state specific campaigns price differently, and some litigations only make sense in certain jurisdictions. Where you practice shapes what a claimant is worth and what one costs to find.
Exclusivity. A claimant delivered to your firm only is worth more, and costs more, than one shared across a list of buyers. If a price looks low, the first question is how many other firms receive the same person.
Whether intake and signing are included. A raw qualified lead, a lead worked by a trained intake team, and a signed case are three different products wearing similar names. Much of the apparent price spread in this market is just these three being compared as if they were one thing.
Why per lead prices cannot be compared across torts
Firms new to mass tort often ask for the going rate per lead, as if there were one. There is not, and the reason is structural. A lead is not a standardized unit. The cost of producing a qualified claimant for a large, mature pharmaceutical docket has almost nothing in common with producing one for a narrow device litigation with strict procedure requirements and a short exposure window.
Comparing a per lead quote from one tort against another is comparing the scarcity of two different populations, the strictness of two different criteria sets, and the maturity of two different dockets. The only comparison that means anything is between providers quoting the same tort, the same criteria, and the same delivery standard. Force every quote onto that footing and the real differences, exclusivity, intake quality, and consent documentation, finally become visible.
Questions that reveal whether a quote is real
A few direct questions will tell you whether the number in front of you was built or invented.
Ask what the price assumes about your criteria, and what happens to it if you tighten them. A real quote moves when the criteria move, and the provider can tell you roughly how. Ask whether the claimants are exclusive to your firm and get the answer in writing. Ask what arrives with each lead: the screening notes, the intake record, and the consent documentation behind it. Ask what signed case pricing includes, if it is offered: whose agreement is signed, what qualification standard is applied, and what happens when a signed claimant turns out to be ineligible. Ask what the campaign minimums are and why, in terms of the tort’s actual claimant volume rather than sales policy.
Vague answers to any of these mean the price was a door opener. Specific answers, including specific limits on what the provider cannot deliver, are what a real operation sounds like.
A quote comparison worksheet
Use the same worksheet for every provider. If a field is left blank, treat that blank as part of the quote.
- Litigation, claim type, and claimant definition
- Qualification criteria, copied word for word
- States, venues, and other geographic limits
- Buying model and the exact unit being priced
- Exclusivity, resale, and reuse terms
- Screening, intake, follow up, and signing work included
- Information and consent records delivered with each claimant
- Reasons a delivery can be rejected and the remedy offered
- Volume assumptions, capacity limits, and delivery timing
- Reporting schedule and campaign review points
- Changes that can alter the price after launch
The worksheet prevents a common mistake: comparing a complete offer with a partial one because the partial offer has the simpler headline. It also gives your firm a record to revisit when the first deliveries raise questions about criteria, quality, or scope.
Why one flat mass tort price is a red flag
Some providers publish a single per lead price for mass tort as if it applied to every litigation on their menu. Given everything above, you can see the problem. The same price cannot honestly cover a mature docket with a large claimant pool and a narrow emerging one, strict criteria and loose ones, national campaigns and single state ones. A flat price usually means one of three things: the leads are shared, the criteria are whatever the provider finds convenient rather than what your firm signs to, or the price quietly changes once you are committed.
Contrast that with practice areas where the product is standardized. Our own MVA pages publish prices openly, because a car accident case profile is consistent enough for a price list to be honest. Mass tort is not built that way, and pretending otherwise is a sales technique, not a pricing model. On our campaigns the number is quoted per tort, per criteria set, and per geography, before any money moves.
How campaign minimums and test budgets should be discussed
A minimum is not automatically a red flag. Finding scarce claimants can require setup, creative testing, screening work, and enough delivery volume to judge quality. The problem is a minimum that nobody can explain.
Ask what the minimum covers, why the claimant pool supports it, and what decision the test is designed to produce. A useful test has a fixed scope, a defined review point, and agreed measures for delivery, qualification, contact, and signing. Ask what happens if volume runs high or low, whether criteria can change midstream, and what choices you will have at the review: expand, adjust, pause, or stop.
Do not let a test quietly become an open ended commitment. If the provider cannot describe what will be learned and when both sides will judge it, the budget is not really a test budget.
Judge a first campaign by cost per signed case
Before launch, define a signed case in writing and use that definition throughout the test. Then track the funnel in separate buckets:
- Claimants delivered
- Claimants who meet the agreed criteria
- Claimants successfully contacted
- Claimants who complete intake
- Cases signed on your firm’s agreement
- Cases later disqualified, with the reason recorded
At the review, divide the total campaign cost by the number of cases in the signed bucket. Also note the staff time your firm spent working the campaign, because a low outside cost can hide a heavy internal load. Compare the result only with campaigns using the same tort, criteria, and signed case definition. Decide from that full picture whether to expand, revise the criteria, change the buying model, or stop.
What to send a provider before you ask for a number
A short written brief produces a better quote than a general pricing call. Send the litigation and claim type, the criteria your firm actually signs to, and any facts that must be documented at the lead stage. Add the states and venue limits you will accept, the buying model you want priced, and whether your team or the provider will handle intake and signing.
Also state what must arrive with each claimant, including screening notes and consent documentation, plus any filing or timing limits your firm is tracking. Mark which criteria are firm requirements and which are preferences. That distinction lets the provider show the price and volume effect of each choice instead of burying it in one unexplained number.
How to get a number you can trust
Bring three things to the conversation: the litigation you want, the exact criteria your firm signs to, and the states you want claimants from. With those, a provider can scope the claimant pool and quote a campaign that reflects reality. Without them, any number you hear is theater.
If the quote works for your firm, you have lost nothing but a phone call getting there. It is the standard to hold every provider to, including us. Start with how a mass tort campaign is scoped and quoted, then get current pricing for the tort you are actually building.
